Atlas Trials

Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients

Clinical trial NCT06416436 · WITHDRAWN

Trial details

NCT number
NCT06416436
Sponsor
University of Kansas Medical Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2024-07-15
Primary completion
2024-07-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.